Inventor
TAKERU FURUYA
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
C07CAcyclic or carbocyclic compounds6%
PatentTitleYear
12,497,399Fluorinated integrin antagonists202512,286,432Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof202511,858,900Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives202411,685,738Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof202311,685,737Fluorinated integrin antagonists2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to OCUTERRA THERAPEUTICS INC (5)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OCUTERRA THERAPEUTICS INC | 5 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2025 |